Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lonza
Biotech
Lonza lands new CEO—Chutes & Ladders
Lonza nabs new CEO after acquiring Roche site. Amgen R&D leader jumps to Acadia. Three C-suite leaders depart I-Mab.
Gabrielle Masson
,
Max Bayer
Apr 5, 2024 8:30am
GSK loses R&D leader—Chutes & Ladders
Sep 22, 2023 9:30am
FDA sinks Allarity’s plans for lead oncology asset
Aug 2, 2022 2:41pm
Moderna COVID-19 vax gets FDA panel’s backing despite concerns
Dec 17, 2020 5:58pm
Lonza poaches Roche vet Ruffieux as newest CEO—Chutes & Ladders
Jun 11, 2020 12:55pm
Lonza seeking experience in CEO successor—Chutes & Ladders
Jan 24, 2020 9:30am